Assessment of radiologic response to targeted therapies in patients with hepatocellular carcinoma. (Q38268169)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25396778 AND SRC:MED&resulttype=core&format=json

22 February 2020

review article

1 reference

title

Assessment of radiologic response to targeted therapies in patients with hepatocellular carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25396778 AND SRC:MED&resulttype=core&format=json

22 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25396778 AND SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Rodolfo Sacco

series ordinal

1

1 reference

1 September 2017

language of work or name

English

0 references

publication date

1 October 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25396778 AND SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25396778 AND SRC:MED&resulttype=core&format=json

22 February 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25396778 AND SRC:MED&resulttype=core&format=json

22 February 2020

issue

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25396778 AND SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

2073-2079

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25396778 AND SRC:MED&resulttype=core&format=json

Sorafenib in advanced hepatocellular carcinoma

22 February 2020

cites work

1 reference

Microvessel density and clinicopathological characteristics in hepatitis C virus and hepatitis B virus related hepatocellular carcinoma

21 January 2018

1 reference

Cystic changes in hepatic metastases from gastrointestinal stromal tumors (GISTs) treated with Gleevec (imatinib mesylate).

21 January 2018

1 reference

Beyond RECIST: molecular and functional imaging techniques for evaluation of response to targeted therapy.

21 January 2018

1 reference

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

Modified RECIST (mRECIST) assessment for hepatocellular carcinoma

21 January 2018

1 reference

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

21 January 2018

1 reference

Which Response Criteria Best Help Predict Survival of Patients with Hepatocellular Carcinoma Following Chemoembolization? A Validation Study of Old and New Models

21 January 2018

1 reference

Comparison of the methods for tumor response assessment in patients with hepatocellular carcinoma undergoing transarterial chemoembolization

21 January 2018

1 reference

Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma.

21 January 2018

1 reference

Evaluation of the mRECIST and α-fetoprotein ratio for stratification of the prognosis of advanced-hepatocellular-carcinoma patients treated with sorafenib.

21 January 2018

1 reference

Identification of responders to sorafenib in hepatocellular carcinoma: is tumor volume measurement the way forward?

21 January 2018

1 reference

Early MRI response monitoring of patients with advanced hepatocellular carcinoma under treatment with the multikinase inhibitor sorafenib

21 January 2018

1 reference

Advanced Hepatocellular Carcinoma: early evaluation of response to targeted therapy and prognostic value of Perfusion CT and Dynamic Contrast Enhanced-Ultrasound. Preliminary results

21 January 2018

1 reference

Assessment of response to sorafenib in advanced hepatocellular carcinoma using perfusion computed tomography: results of a pilot study.

21 January 2018

1 reference

Treatment Planning and Volumetric Response Assessment for Yttrium-90 Radioembolization: Semiautomated Determination of Liver Volume and Volume of Tumor Necrosis in Patients with Hepatic Malignancy

21 January 2018

1 reference

Quantitative and volumetric European Association for the Study of the Liver and Response Evaluation Criteria in Solid Tumors measurements: feasibility of a semiautomated software method to assess tumor response after transcatheter arterial chemoembo

21 January 2018

1 reference

MDCT necrosis quantification in the assessment of hepatocellular carcinoma response to yttrium 90 radioembolization therapy: comparison of two-dimensional and volumetric techniques.

21 January 2018

1 reference

Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma

21 January 2018

1 reference

Molecular determinants of outcome in sorafenib-treated patients with hepatocellular carcinoma.

21 January 2018

1 reference

Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma

21 January 2018

1 reference

Early increase in α-fetoprotein for predicting unfavorable clinical outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib

21 January 2018

1 reference

Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue--initial experience

21 January 2018

1 reference

Early antiangiogenic activity of bevacizumab evaluated by computed tomography perfusion scan in patients with advanced hepatocellular carcinoma

21 January 2018

1 reference

Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring

21 January 2018

1 reference

Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound

21 January 2018

1 reference

Perfusion characterization of liver metastases from endocrine tumors: Computed tomography perfusion

21 January 2018

1 reference

Monitoring Response to Antiangiogenic Treatment and Predicting Outcomes in Advanced Hepatocellular Carcinoma Using Image Biomarkers, CT Perfusion, Tumor Density, and Tumor Size (RECIST)

21 January 2018

1 reference

Advanced Hepatocellular Carcinoma: Early Evaluation of Response to Bevacizumab Therapy at Dynamic Contrast-enhanced US with Quantification—Preliminary Results 1

21 January 2018

1 reference

Relationship between baseline hepatic status and outcome, and effect of sorafenib on liver function: SHARP trial subanalyses

21 January 2018

1 reference

Changes in Tumor Density in Patients with Advanced Hepatocellular Carcinoma Treated with Sunitinib

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/FON.14.92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25396778 AND SRC:MED&resulttype=core&format=json

22 February 2020

1 reference